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Abstract 
Epilepsy is a central nervous system disorder, which involves spontaneous and repeated seizures. The 
seizures are triggered by abnormal, irregular excitation in the brain.  NMDA receptors, a type of brain 
glutamate receptor, have been implicated in the development of seizures.  Many drug therapies for 
epilepsy cause various side effects, toxicities and drug interactions.  Thus, there is a need to develop 
new drug regimens, which have minimal side effects.  Hydra's nervous system relies on the same 
transmitters and receptors, (including the NMDA glutamate receptor), as does the human nervous 
system.  Thus, we propose to assess hydra as an invertebrate model for screening new compounds for 
beneficial activity, including anti-seizure activity.   
It is possible to assess the effect of chemicals on hydra’s behavior by visually recording the sequence of 
behaviors of hydra’s body and tentacles.  This pattern of behaviors has been cataloged into what is 
referred to as a formal ethogram (a list of discrete behaviors typically employed by a species).  The 
ethogram allows for quantification, and therefore statistical analysis, of characteristic movements.   
Hydra will be cultured using the protocol described by Lenhoff (1983). The behavior of the animal will be 
observed for 20 minutes under the microscope and recorded with an Infinity camera. Six repeated 
experiments would be performed at each concentration with each applied substance.  The ethogram 
developed by (Flanagan et al, 1995) will be used to list and statistically collect the behavioral data. An 
analysis of variance of the collected data will be performed. A dose response graph will be generated for 
each drug and will be compared with its negative control including the other applied substances.  Final 
statistical analysis of the dose response graphs produced will be completed by using F-tests for the EC50 
of each compound.   
